Contents
Hospice cap fraud uses false admissions, manipulated patient movement or concealed repayment obligations to keep Medicare money above a provider’s annual payment ceiling. The cap ties that ceiling to beneficiary shares, giving management a financial reason to change who enters hospice, who leaves and which provider bills. For an insider, this form of hospice fraud can connect a finance spreadsheet to a decision made about a patient. The cap forecast, admission instructions and discharge records may tell the same story from different desks. Patients become a way to balance the ledger, while taxpayers lose money the hospice owes back.
The Medicare hospice aggregate cap limits a provider’s annual Medicare payments to the applicable cap amount multiplied by its allocated beneficiary count. When payments exceed that ceiling, the hospice owes the excess back.
The count includes whole or fractional beneficiary shares. Additional qualifying shares raise the ceiling, making the timing and allocation of admissions financially consequential.
For fiscal 2027, the Centers for Medicare & Medicaid Services set the aggregate cap amount at $36,175 per beneficiary. The cap year runs from October 1 through September 30.
The Medicare billing number defines the pool of payments and patients being compared. In its annual filing for 2025, Chemed reported 59 VITAS programs operating under 33 Medicare provider numbers. A branch’s census therefore tells only part of the financial story. The other programs billing through the same number belong in the calculation too.
Medicare’s daily payment rewards enrolled days, while the aggregate cap ties the annual ceiling to beneficiary shares. Routine home care pays by the day even when nobody visits. Costs tend to be higher around admission and death, leaving the less intensive middle of a stay financially attractive.
Milliman’s Hospice Medicare Margins report, commissioned by the National Partnership for Hospice Innovation in 2019, found an instructive break in that pattern. Margins generally rose across groups with longer average stays, then fell in the group with the longest stays. The report identified the aggregate cap as the likely reason: more hospice days for fewer patients make the ceiling harder to avoid.
That is where the business incentive can change direction. Keeping existing patients generates more daily payments. Adding qualifying beneficiary shares creates more room under the cap. In a 2010 filing to investors, Chemed reported that January admissions at one program had been sufficient to eliminate its billing limitation. A provider’s response to cap pressure can begin in the admissions department.
False admissions can turn a payment ceiling into a recruitment target. A whistleblower complaint concerning AseraCare alleged that its corporate operator directed centers to admit patients who did not meet hospice standards to avoid returning money above the Medicare cap.
A separate complaint concerning AseraCare’s Mobile operation alleged pressure in the opposite direction. An executive allegedly ordered the discharge of patients whose stays exceeded 180 days, regardless of their medical condition or prognosis, to avoid aggregate-cap exposure. The same complaint described previously discharged patients being enrolled again to increase the census.
These allegations put hospice eligibility and the financial instruction side by side. In the discharge allegation, avoiding cap repayment took precedence over the patient’s medical condition.
For clinical staff, the revealing comparison is the patient’s condition and recommendation against the instruction that followed. For finance staff, it is the same instruction against the cap forecast. Together, those records can show whose problem the patient movement was intended to solve.
Shifting patients between provider numbers can change where payments and beneficiary shares enter the hospice cap calculation. The useful evidence follows the patient through both providers and connects the transfer to the financial decision behind it.
The whistleblower complaint against Odyssey Healthcare placed a transfer decision after its acquisition of VistaCare. It alleged a financial purpose for moving the patients:
The VistaCare Philadelphia program, after the acquisition by Defendant, transferred their patients with the greatest amount of days to the Philadelphia Odyssey program during the period of July 2008 – September 2008 in order to minimize patient day averages in the VistaCare program, but increase the days at the Philadelphia program.
The allegation names the business reason for the movement. We trace the billing numbers, payments and allocated beneficiary shares on each side to see how the transfer affected the cap exposure.
A hospice acquisition can bring cap liability into the buyer’s accounts along with the patient census. Odyssey’s financial disclosures for 2009 recorded cap balances acquired from VistaCare. The acquired business carried $8.2 million of accrued cap liability into the transaction. Across its operations, Odyssey reported $9.407 million in cap refunds to Medicare in 2009.
For a hospice acquisition involving cap liability, financial disclosures need to be read beside the provider-number history. We examine whether the cap schedules given to the buyer match the schedules finance used internally, and how those figures connect to later repayments.
Hospice cap liability hidden from Medicare puts the internal calculation and the company’s treatment of the debt at the center of the inquiry. The important comparison is what finance calculated, what management learned and what the provider disclosed or repaid.
A liability entry can show that finance recognized the exposure. Instructions to admissions or clinical staff can show how management chose to respond.
We connect those records with the claims and payments for the same provider number and cap year. That keeps the question specific: what money did the hospice owe, who understood the obligation and what happened to it?
In a hospice cap overpayment case, evidence that management knew repayment was due connects the calculation to the decision to keep the money. Finance and compliance staff may have seen the warning arrive, the exposure discussed and the response approved.
Caris Healthcare shows why that response matters in a broader hospice overpayment case. The company agreed to an $8.5 million settlement in 2018 over allegations involving ineligible patients and retained payments. The Justice Department alleged that internal audits, the chief medical officer and nurses had raised eligibility concerns. Caris allegedly kept billing and took no meaningful action to identify payments it had already received improperly.
The settlement provided a $1.4 million whistleblower reward for the nurse, a former employee who brought the case. A whistleblower case under the False Claims Act can pay 15% to 30% of what the government recovers.
The Centers for Medicare & Medicaid Services describes churn and burn as a hospice opening and billing, then shutting down when it faces an audit or reaches its annual payment limit. The operator keeps the money, buys another Medicare billing number, transfers patients and begins billing again. The agency set out that pattern in its hospice enrollment moratorium notice.
Here, the provider number becomes disposable while the patients keep generating payments. The cap has become a reason to abandon the billing identity carrying the exposure. Ownership, enrollment and transfer records connect the departing provider to the next one.
Evidence of hospice cap fraud connects the provider-number calculation, patient movement and management’s decisions. Those records often sit on different desks. We work with insiders to connect what finance calculated with what admissions, clinical and billing staff were told to do.
The insider’s value is knowing why the entries changed. A forecast can show that management expected a repayment. A message can explain why a group of patients suddenly moved. We bring the financial and clinical evidence together to build the case around the decisions behind the numbers.
If you know why a hospice changed admissions, moved patients or kept money it owed Medicare, speak with our whistleblower experts about the decisions behind the cap debt. We build your strongest hospice whistleblower case from the finance, clinical and billing records, bring in hospice fraud whistleblower lawyers who understand cap calculations and repayment disputes, and stay beside you throughout the case.